Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Tracking development assistance for health from China, 2007-2017.

Tytuł :
Tracking development assistance for health from China, 2007-2017.
Autorzy :
Micah AE; Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Zhao Y; Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Chen CS; Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Zlavog BS; Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Tsakalos G; Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Chapin A; Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Gloyd S; Department of Global Health, University of Washington, Seattle, Washington, USA.
Jonas J; Ophthalmology, Medical Faculty Mannheim of the Ruprecht Karl University of Heidelberg, Mannheim, Germany.
Lee PH; School of Nursing, Hong Kong Polytechnic University, Hong Kong, China.
Liu S; National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, Hubei, China.
Ng MTA; Tencent Healthcare, Shenzhen, Guangdong, China.
Phillips MR; Shanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China.
Rubagotti E; Biotechnology, Universidad Regional Amazónica Ikiam, Ciudad de Tena, Napo, Ecuador.
Tang K; Research Center for Public Health, Tsinghua University School of Medicine, Beijing, Hubei, China.
Tang S; Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
Younis M; Department of Health Economics & Management, Jackson State University, Jackson, Mississippi, USA.
Zhang Y; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan, Hubei, China.
Murray CJL; Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Dieleman JL; Institute for Health Metrics and Evaluation, Seattle, Washington, USA.
Pokaż więcej
Źródło :
BMJ global health [BMJ Glob Health] 2019 Oct 08; Vol. 4 (5), pp. e001513. Date of Electronic Publication: 2019 Oct 08 (Print Publication: 2019).
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Original Publication: [London] : BMJ Publishing Group Ltd, [2016]-
References :
Lancet. 2018 Sep 22;392(10152):998-999. (PMID: 30264715)
Glob Health Res Policy. 2017 Aug 9;2:24. (PMID: 29202092)
Lancet. 2019 Jun 1;393(10187):2233-2260. (PMID: 31030984)
Lancet. 2015 Dec 12;386(10011):2379-80. (PMID: 26700520)
Lancet. 2018 Aug 25;392(10148):636. (PMID: 30152343)
Lancet. 2017 Dec 9;390(10112):2595-2601. (PMID: 29231838)
Global Health. 2014 Dec 30;10:84. (PMID: 25547314)
Glob Chall. 2017 Jan 30;1(2):1600001. (PMID: 31565261)
Contributed Indexing :
Keywords: Health economics; Health policy; Health systems
Entry Date(s) :
Date Created: 20191025 Latest Revision: 20191027
Update Code :
20201218
PubMed Central ID :
PMC6782043
DOI :
10.1136/bmjgh-2019-001513
PMID :
31646007
Czasopismo naukowe
Introduction: In recent years, China has increased its international engagement in health. Nonetheless, the lack of data on contributions has limited efforts to examine contributions from China. Existing estimates that track development assistance for health (DAH) from China have relied primarily on one dataset. Furthermore, little is known about the disbursing agencies especially the multilaterals through which contributions are disbursed and how these are changing across time. In this study, we generated estimates of DAH from China from 2007 through 2017 and disaggregated those estimates by disbursing agency and health focus area.
Methods: We identified the major government agencies providing DAH. To estimate DAH provided by each agency, we leveraged publicly available development assistance data in government agencies' budgets and financial accounts, as well as revenue statements from key international development agencies such as the WHO. We reported trends in DAH from China, disaggregated contributions by disbursing bilateral and multilateral agencies, and compared DAH from China with other traditional donors. We also compared these estimates with existing estimates.
Results: DAH provided by China grew dramatically, from US$323.1 million in 2007 to $652.3 million in 2017. During this period, 91.8% of DAH from China was disbursed through its bilateral agencies, including the Ministry of Commerce ($3.7 billion, 64.1%) and the National Health Commission ($917.1 million, 16.1%); the other 8.2% was disbursed through multilateral agencies including the WHO ($236.5 million, 4.1%) and the World Bank ($123.1 million, 2.2%). Relative to its level of economic development, China provided substantially more DAH than would be expected. However, relative to population size and government spending, China's contributions are modest.
Conclusion: In the current context of plateauing in the growth rate of DAH contributions, China has the potential to contribute to future global health financing, especially financing for health system strengthening.
(© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies